(Q38723221)

5 September 2017

1 reference

title

Cefixime. A review of its antibacterial activity. Pharmacokinetic properties and therapeutic potential (English)

1 reference

5 September 2017

1 reference

1

Brogden RN

1 reference

5 September 2017

Campoli-Richards DM

2

1 reference

5 September 2017

1 October 1989

1 reference

5 September 2017

1 reference

5 September 2017

38

1 reference

5 September 2017

4

1 reference

5 September 2017

524-550

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-198938040-00004

5 September 2017

0 references

cites work

In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.

1 reference

12 December 2020

In vitro comparison of activity of cefixime with activities of other orally administered antimicrobial agents

1 reference

12 December 2020

[A parallel comparative double blind study of cefixime with cefaclor in the treatment of acute suppurative otitis media in children]

1 reference

12 December 2020

Pharmacokinetics and clinical effects of cefixime in pediatrics

1 reference

12 December 2020

[A parallel comparative double blind study of cefixime with cefroxadine in the treatment of acute lacunar tonsillitis]

1 reference

12 December 2020

Pharmacokinetic profile of cefixime in man.

1 reference

12 December 2020

In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens

1 reference

12 December 2020

A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients.

1 reference

12 December 2020

[Clinical study on cefixime granules in the field of pediatrics].

1 reference

12 December 2020

In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida

1 reference

12 December 2020

[Tonsil diffusion of cefixime in children]

1 reference

12 December 2020

[Fundamental and clinical studies on cefixime in pediatrics].

1 reference

12 December 2020

Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections

1 reference

12 December 2020

[Fundamental and clinical studies of cefixime in children]

1 reference

12 December 2020

A general practice comparative study of a new third-generation oral cephalosporin, cefixime, with amoxycillin in the treatment of acute paediatric otitis media.

1 reference

12 December 2020

[Clinical experience with cefixime in the pediatric field]

1 reference

12 December 2020

Pharmacokinetics of cefixime after once-a-day and twice-a-day dosing to steady state

1 reference

12 December 2020

Phase I study of cefixime, a new oral cephalosporin

1 reference

12 December 2020

Mechanism of action of the new orally active cephalosporin FK027.

1 reference

12 December 2020

Cefixime vs. cefaclor in the treatment of acute otitis media in infants and children

1 reference

12 December 2020

[Clinical studies on cefixime in pediatrics]

1 reference

12 December 2020

Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin

1 reference

12 December 2020

In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria

1 reference

12 December 2020

Comparative in vitro activity of the new oral cephalosporin cefixime.

1 reference

12 December 2020

Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiency

1 reference

12 December 2020

Pharmacokinetics of cefixime in the young and elderly

1 reference

12 December 2020

In vitro activity of cefixime (CL284635) and other antimicrobial agents against Haemophilus isolates from pediatric patients

1 reference

12 December 2020

Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin

1 reference

12 December 2020

In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic

1 reference

12 December 2020

Absolute bioavailability of cefixime in man

1 reference

12 December 2020

Randomized, open label, multicenter trial of cefixime compared with amoxicillin for treatment of acute otitis media with effusion.

1 reference

12 December 2020

Cefixime: spectrum of antibacterial activity against 16,016 clinical isolates.

1 reference

12 December 2020

Clinical experience with cefixime in the pediatric infections

1 reference

12 December 2020

Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone

1 reference

12 December 2020

Clinical studies of cefixime in pediatric field

1 reference

12 December 2020

Bacteriologic and clinical efficacy of cefixime compared with amoxicillin in acute otitis media.

1 reference

12 December 2020

The pharmacokinetic and bactericidal characteristics of oral cefixime

1 reference

12 December 2020

Fundamental and clinical studies on cefixime (5% granules) in the pediatric field

1 reference

12 December 2020

Bowel flora changes in humans receiving cefixime (CL 284,635) or cefaclor

1 reference

12 December 2020

Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections

1 reference

12 December 2020

Determination of cefixime in biological samples by reversed-phase high-performance liquid chromatography

1 reference

12 December 2020

Serum protein binding of a new oral cephalosporin, CL 284,635, in various species

1 reference

12 December 2020

[Fundamental and clinical studies on cefixime in the pediatric field].

1 reference

12 December 2020

The beta-lactamases of gram-negative bacteria and their possible physiological role.

1 reference

12 December 2020

Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains.

1 reference

12 December 2020

Noncomparative, open label, multicenter trial of cefixime for treatment of bacterial pharyngitis, cystitis and pneumonia in pediatric patients

1 reference

12 December 2020

The pharmacokinetics of cefixime in the fasted and fed state.

1 reference

12 December 2020

Susceptibility of multiply resistant Haemophilus influenzae to newer antimicrobial agents.

1 reference

12 December 2020

Safety profile of cefixime

1 reference

12 December 2020

Comparison of cefixime and co-trimoxazole in acute uncomplicated urinary tract infection. A double-blind general practice study.

1 reference

12 December 2020

[Fundamental and clinical studies of cefixime granules in pediatrics]

1 reference

12 December 2020

In vitro susceptibility of Haemophilus influenzae to cefixime

1 reference

12 December 2020

Comparison of ciprofloxacin and beta-lactam antibiotics in the treatment of urinary tract infections and alteration of fecal flora

1 reference

12 December 2020

10.2165/00003495-198938040-00004

Identifiers

DOI

1 reference

PubMed ID

2684593

Dimensions Publication ID

5 September 2017

0 references

1 reference

PubMed ID

2684593